Researchers at the Bonn University Department of Ophthalmology and US colleagues successfully implanted new cells under the retina
Age-related macular degeneration (AMD) is the most frequent cause of blindness. Scientists at the Department of Ophthalmology at the Bonn University Hospital and from the Neural Stem Cell Institute in New York (USA) have developed a method for using stem cells to replace cells in the eye destroyed by AMD. The implants survived in rabbit eyes for several weeks. Additional research is needed for clinical application. The results are now presented in the journal “Stem Cell Reports”.
About four and a half million people in Germany suffer from age-related macular degeneration (AMD). It is associated with a gradual loss of visual acuity and the ability to read or drive a car can be lost. The center of the field of vision is blurry, as if covered by a veil. This is caused by damage to a cell layer under the retina, known as the retinal pigment epithelium (RPE). It coordinates the metabolism and function of the sensory cells in the eye. Inflammatory processes in this layer are associated with AMD and “metabolic waste” is less efficiently recycled. To date, there is no cure for AMD; treatments can only relieve the symptoms.
Scientists from the Bonn University Department of Ophthalmology, together with researchers in New York (USA), have now tested a new method in rabbits by which the damaged RPE cells in AMD may be replaced. The researchers implanted different RPEs which were obtained, among others, from stem cells from adult human donors. “These cells have now been used for the first time in research for transplantation purposes,” says lead author Dr. Boris V. Stanzel from the Department of Ophthalmology at the University of Bonn. The discovery and characterization of the adult RPE stem cells was performed in the group of Prof. Sally Temple and Dr. Jeffrey Stern from the Neural Stem Cell Institute (NSCI) in New York, USA. Dr. Timothy Blenkinsop at NSCI pioneered methods to grow them to closely resemble true RPE.
Researchers in Bonn developed the implantation techniques
The implantation techniques for the new method were developed by researchers working with Dr. Stanzel from the Department of Ophthalmology at the University of Bonn. They allowed the stem cell derived RPE to grow on small polyester discs, thus yielding a thin cell layer. The researchers implanted this human RPE monolayer in rabbits under the retina. “Our research group developed special instruments to implant the replacement cells can under the retina,” reports Dr. Stanzel. After four days, the researchers used tomographic methods to check whether the replacement cells had integrated into the surrounding cell layers. “The implanted cells were alive,” reports the researcher at the Department of Ophthalmology at the University of Bonn. “That is a clear indication that they have joined with the surrounding cells.” After one week, the implanted cell layer was still stable. Even after four weeks, tissue examinations showed that the transplant was intact.
A new approach for possible treatment of AMD
“The results from the experiments prove that retinal pigment epithelial cells obtained from adult stem cells have the potential to replace cells destroyed by age-related macular degeneration,” summarizes Dr. Stanzel. Moreover, using the newly developed basic method, it will be possible in the future to test which stem cell lines are suitable for transplantation in the eye. “However, clinical application is still far away,” says Dr. Stanzel. More research is needed.
The Latest on: Macular degeneration
via Google News
The Latest on: Macular degeneration
- Nano Retina Announces Preliminary Results for First-in-Human Implantation of Its NR600 Artificial Retina Deviceon March 30, 2020 at 12:10 am
The device is designed to restore vision to persons blinded by age-related macular degeneration and retinitis pigmentosa First two patients to receive the device in March 2020 report visual effect ...
- McDonald's Cites Justices' Comcast Ruling To Avoid ADA Suiton March 27, 2020 at 8:30 pm
Morey, a California resident who is unable to drive a car at night because of macular degeneration, sued McDonald's in Illinois federal court in February 2018, saying the chain discriminates against ...
- A device for the early detection of certain eyesight problemson March 27, 2020 at 6:45 am
The technology could be extremely useful for ophthalmologists, in particular for detecting age-related macular degeneration early and assessing new treatment options. The retina is a complex tissue ...
- Juvenile Macular Degeneration (Stargardt Disease) Pipeline Review, H1 2020 - ResearchAndMarkets.comon March 27, 2020 at 4:39 am
Pipeline Review, H1 2020" drug pipelines has been added to ResearchAndMarkets.com's offering. This pipeline guide Juvenile Macular Degeneration (Stargardt Disease) Pipeline Review, H1 2020, provides ...
- Global Eye Care Supplements Market 2020: Analysis By Sales Market Segment, Size And Evolution Rate by Type and Application Forecast To 2024on March 27, 2020 at 3:55 am
Final Report will add the analysis of the impact of COVID-19 on this industry" Global “Eye Care Supplements Market” Research Report2020-2024 offers executive summary along with data analysis of the ...
- Emerging Drug Delivery Systems for Posterior Segment Diseaseon March 26, 2020 at 5:56 pm
The intravitreal injection has been the mainstay of treatment for the retina specialist for more than a decade in treating a number of blinding conditions such as macular degeneration, retinovascular ...
- Genentech Says It Shouldn't Lose Patent Rights Over Erroron March 26, 2020 at 4:19 pm
The biotechnology company is fighting to extend what's known as a supplementary protection certificate, or SPC, for an antibody marketed under the brand name Lucentis used to treat an eye disorder ...
- seeBOOST Electronic Glasses Improve Central Vision: Interview with CEO Patrick Antakion March 25, 2020 at 2:12 pm
Central vision loss is a devastating complication of diseases such as diabetes and macular degeneration. Because central vision is responsible for visual acuity, loss of it can severely affect one’s ...
- A tooth-enamel protein is found in eyes with a common form of macular degenerationon March 23, 2020 at 5:05 am
Deposits of a mineral found in tooth enamel at the back of the eye could be hastening the progression of age-related macular degeneration, the leading cause of deteriorating eyesight in people over 50 ...
- RIBOMIC Enters License Agreement with AJU Pharma for RBM-007 in Age-related Macular Degenerationon March 17, 2020 at 5:05 pm
RIBOMIC has signed the license agreement with AJU PHARM CO., LTD., Korean pharmaceutical company for RBM-007 licensing agreement.
via Bing News